journal
https://read.qxmd.com/read/39241536/lupus-prone-nzm2328-mice-exhibit-enhanced-uv-induced-myeloid-cell-recruitment-and-activation-in-a-type-i-interferon-dependent-manner
#1
JOURNAL ARTICLE
Mitra P Maz, Alayka L Reddy, Celine C Berthier, Lam C Tsoi, Deborah J Colesa, Sonya J Wolf, Hong Shi, Shannon N Loftus, Rezvan Moallemian, Rachael Bogle, Matthias Kretzler, Chaim O Jacob, Johann E Gudjonsson, J Michelle Kahlenberg
Though the exact causes of systemic lupus erythematosus (SLE) remain unknown, exposure to ultraviolet (UV) light is one of the few well-known triggers of cutaneous inflammation in SLE. However, the precise cell types which contribute to the early cutaneous inflammatory response in lupus, and the ways that UV dosing and interferons modulate these findings, have not been thoroughly dissected. Here, we explore these questions using the NZM2328 spontaneous murine model of lupus. In addition, we use iNZM mice, which share the NZM2328 background but harbor a whole-body knockout of the type I interferon (IFN) receptor, and wild-type BALB/c mice...
September 5, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39232430/amelioration-of-immunoglobulin-a-vasculitis-by-suppression-of-the-pathological-expansion-of-t-follicular-helper-17%C3%A2-cells
#2
JOURNAL ARTICLE
Qinglian Jiang, Xuyang Chi, Tong Wei, Shingo Nakayamada, Yu Shan, Yini Sun, Xing Zhao, Jieqing Zhou, Yan Fan, Jia Gu, Hong Jiang, Xiaoxue Ma
The main pathogenic features of immunoglobulin A vasculitis (IgAV) are overactive B cells and elevated production of IgA, which requires help from T follicular helper 17 (Tfh17) cells. To evaluate the pathological role of Tfh17 cells in IgAV, we investigated the mechanism responsible for Tfh17 differentiation and explored how to ameliorate IgAV by modulating Tfh17 generation. Peripheral blood mononuclear cells from IgAV patients were analyzed by flow cytometry. In vitro culture was performed to assess the modulation of cytokine-induced phenotypes...
September 3, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39163739/high-throughput-screening-identifies-repurposable-drugs-for-modulation-of-innate-and-acquired-immune-responses
#3
JOURNAL ARTICLE
Saeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, Linda Heimberg, Malin Krause, Wendelien Veldkamp, Moritz Magens, Johannes Zanken, Kerstin J Neuschutz, David A De Luca, Khalaf Kridin, Gestur Vidarsson, Lenche Chakievska, Remco Visser, Sven Kunzel, Andreas Recke, Yask Gupta, Katharina Boch, Artem Vorobyev, Kathrin Kalies, Rudolf A Manz, Katja Bieber, Ralf J Ludwig
A balanced immune system is essential to maintain adequate host defense and effective self-tolerance. While an immune system that fails to generate appropriate response will permit infections to develop, uncontrolled activation may lead to autoinflammatory or autoimmune diseases. To identify drug candidates capable of modulating immune cell functions, we screened 1200 small molecules from the Prestwick Chemical Library for their property to inhibit innate or adaptive immune responses. Our studies focused specifically on drug interactions with T cells, B cells, and polymorphonuclear leukocytes (PMNs)...
August 19, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39146891/telitacicept-a-novel-horizon-in-targeting-autoimmunity-and-rheumatic-diseases
#4
REVIEW
Liuting Zeng, Kailin Yang, Yang Wu, Ganpeng Yu, Yexing Yan, Moujia Hao, Tian Song, Yuwei Li, Junpeng Chen, Lingyun Sun
BLyS and APRIL have the capability to bind to B cells within the body, allowing these cells to evade elimination when they should naturally be removed. While BLyS primarily plays a role in B cell development and maturation, APRIL is linked to B cell activation and the secretion of antibodies. Thus, in theory, inhibiting BLyS or APRIL could diminish the population of aberrant B cells that contribute to SLE and reduce disease activity in patients. Telitacicept functions by binding to and neutralizing the activities of both BLyS and APRIL, thus hindering the maturation and survival of plasma cells and fully developed B cells...
August 14, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39141986/safety-of-biologic-immunosuppressants-in-pregnant-women-with-immune-mediated-inflammatory-diseases
#5
JOURNAL ARTICLE
Martínez-Sánchez N, J Álvarez-Troncoso, Á Robles-Marhuenda, M De la Calle Fernández-Miranda, M L Muner Hernando, J L Bartha
BACKGROUND: Immune-mediated inflammatory diseases (IMIDs) typically affect women of childbearing age. One of the challenges in treating these women during pregnancy is to manage the disease while minimizing or avoiding the use of disease-modifying antirheumatic drugs (DMARDs) that may increase the risk to the mother or fetus. Biologic therapy has transformed the management of these patients. This study aimed to evaluate the maternal-fetal safety and perinatal outcomes in pregnant women with IMID exposed to biologic DMARDs either preconceptionally or during pregnancy and compare them with women using conventional DMARDs and a group of healthy pregnant women...
August 13, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39141985/antigen-specific-t-cells-and-autoimmunity
#6
REVIEW
Manuel Rojas, Yeny Acosta-Ampudia, Luke S Heuer, Weici Zang, Diana M Monsalve, Carolina Ramírez-Santana, Juan-Manuel Anaya, William M Ridgway, Aftab A Ansari, M Eric Gershwin
Autoimmune diseases (ADs) showcase the intricate balance between the immune system's protective functions and its potential for self-inflicted damage. These disorders arise from the immune system's erroneous targeting of the body's tissues, resulting in damage and disease. The ability of T cells to distinguish between self and non-self-antigens is pivotal to averting autoimmune reactions. Perturbations in this process contribute to AD development. Autoreactive T cells that elude thymic elimination are activated by mimics of self-antigens or are erroneously activated by self-antigens can trigger autoimmune responses...
August 13, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39141984/wtap-promotes-the-progression-of-ulcerative-colitis-by-silencing-the-expression-of-ces2-through-m-6-a-modification
#7
JOURNAL ARTICLE
Xiaoran Xie, Sha Cheng, Xiong Chen, Xia Wang
OBJECTIVE: This study will explore the function of WTAP, the critical segment of m6 A methyltransferase complex, in UC and its regulation on immune response. METHODS: The expression levels of key proteins were detected in colon tissues which were derived from UC patients and mice. Macrophage polarization and CD4+ T cell infiltration were detected by flow cytometry and IF staining. ELISA assay was utilized to analyze the level of the inflammatory cytokines. m6 A-RIP-PCR, actinomycin D test, and RIP assays were utilized to detect the m6 A level, stability, and bound proteins of CES2 mRNA...
August 13, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39116634/inflammatory-disease-status-and-response-to-tnf-blockade-are-associated-with-mechanisms-of-endotoxin-tolerance
#8
JOURNAL ARTICLE
Felix Il Clanchy, Federica Borghese, Jonas Bystrom, Attila Balog, Henry Penn, Dobrina N Hull, Rizgar A Mageed, Peter C Taylor, Richard O Williams
The mechanisms of endotoxin tolerance (ET), which down-regulate inflammation, are well described in response to exogenous toll-like receptor ligands, but few studies have focused on ET-associated mechanisms in inflammatory disease. As blocking TNF can attenuate the development of ET, the effect of anti-TNF on the expression of key ET-associated molecules in inflammatory auto-immune disease was measured; changes in inflammatory gene expression were confirmed using an ET bioassay. The expression of immunomodulatory molecules was measured in a murine model of arthritis treated with anti-TNF and the expression of ET-associated molecules was measured in whole blood in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients, before and after therapy...
August 7, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39098251/transcriptomic-analyses-of-lung-tissues-reveal-key-genes-associated-with-progression-of-systemic-sclerosis-interstitial-lung-disease-ssc-ild
#9
JOURNAL ARTICLE
Yehya Al-Adwi, Johanna Westra, Harry van Goor, Leon C van Kempen, Mohammed Osman, C Tji Gan, Wim Timens, Douwe J Mulder
OBJECTIVE: Systemic sclerosis-interstitial lung disease (SSc-ILD) is the leading cause of death in SSc, affecting around 50 % of the patients. Lung tissue of patients with early-stage SSc-ILD is characterized by a predominant inflammatory response with inconspicuous fibrosis, which may progress to honeycombing fibrosis. Hence, a better understanding of the molecular mechanisms underpinning SSc-ILD pathogenesis is needed to improve treatment options and progression prediction. This transcriptomic study aims to reveal the differential gene expression between control (ctrl) lung tissue and inflammatory, prefibrotic and fibrotic lung tissue to capture progression of early to late phase SSc-ILD...
August 3, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39096717/the-binding-of-extracellular-cyclophilin-a-to-ace2-and-cd147-triggers-psoriasis-like-inflammation
#10
JOURNAL ARTICLE
Wenxian Yang, Xiaoyuan Bai, Xiaoxiao Jia, Huizi Li, Jie Min, Heqiao Li, Haoran Zhang, Jianjing Zhou, Yuna Zhao, Wenjun Liu, Haiming Xin, Lei Sun
Psoriasis is a chronic, proliferative, and inflammatory skin disease closely associated with inflammatory cytokine production. Cyclophilin A (CypA) is an important proinflammatory factor; however, its role in psoriasis remains unclear. The present data indicate that CypA levels are increased in the lesion skin and serum of patients with psoriasis, which is positively correlated with the psoriasis area severity index. Furthermore, extracellular CypA (eCypA) triggered psoriasis-like inflammatory responses in keratinocytes...
August 2, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39096716/earlier-vs-later-time-period-of-covid-19-infection-and-emergent-autoimmune-signs-symptoms-and-serologies
#11
JOURNAL ARTICLE
Emily G Oakes, Eilish Dillon, Katherine A Buhler, Hongshu Guan, Misti Paudel, Kathryne Marks, Ifeoluwakiisi Adejoorin, Jeong Yee, Jack Ellrodt, Sara Tedeschi, Jeffrey Sparks, Siobhan M Case, Tiffany Hsu, Daniel H Solomon, A Helena Jonsson, Roberta Vezza Alexander, Deepak A Rao, May Y Choi, Karen H Costenbader
OBJECTIVE: Autoantibodies and autoimmune diseases after SARS-CoV-2 infection are widely reported. Given evolving variants, milder infections, and increasing population vaccination, we hypothesized that SARS-CoV-2 infection earlier in the pandemic would be associated with more autoimmune connective tissue disease (CTD) symptoms and immunologic abnormalities. METHODS: Patients ≥18 years old with COVID-19 3/1/2020-8/15/2022 completed the CTD Screening Questionnaire and were tested for 27 autoimmune serologies, SARS-CoV-2 serologies, cell-bound complement activation products (CB-CAPs), and T and B lymphocyte immunophenotypes by flow cytometry...
August 2, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39084998/a-framework-for-exclusion-of-alternative-diagnoses-in-sarcoidosis
#12
JOURNAL ARTICLE
Logan J Harper, Carol F Farver, Ruchi Yadav, Daniel A Culver
Sarcoidosis is a multisystem granulomatous syndrome that arises from a persistent immune response to a triggering antigen(s). There is no "gold standard" test or algorithm for the diagnosis of sarcoidosis, making the diagnosis one of exclusion. The presentation of the disease varies substantially between individuals, in both the number of organs involved, and the manifestations seen in individual organs. These qualities dictate that health care providers diagnosing sarcoidosis must consider a wide range of possible alternative diagnoses, from across a range of presentations and medical specialties (infectious, inflammatory, cardiac, neurologic)...
July 30, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39084084/shared-aetiology-underlying-multiple-sclerosis-and-other-immune-mediated-inflammatory-diseases-swedish-familial-co-aggregation-and-large-scale-genetic-correlation-analyses
#13
JOURNAL ARTICLE
Qianwen Liu, Yuan Jiang, Thomas Frisell, Pernilla Stridh, Klementy Shchetynsky, Lars Alfredsson, Ingrid Kockum, Ali Manouchehrinia, Xia Jiang
BACKGROUND: While multiple sclerosis (MS) affects less than 1 % of the general population, immune mediated inflammatory diseases (IMIDs) collectively influence 5-10 % of the population. Understanding familial co-aggregation of MS and other IMIDs carries important clinical and public health implications that will enable early detection and personalized treatment. OBJECTIVE: To estimate the familial association between MS and other IMIDs and to quantify their shared genetic basis...
July 30, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39067314/melatonin-synergistically-potentiates-the-effect-of-methylprednisolone-on-reducing-neuroinflammation-in-the-experimental-autoimmune-encephalomyelitis-mouse-model-of-multiple-sclerosis
#14
JOURNAL ARTICLE
Ana Isabel Álvarez-López, Nuria Álvarez-Sánchez, Ivan Cruz-Chamorro, Guillermo Santos-Sánchez, Eduardo Ponce-España, Ignacio Bejarano, Patricia Judith Lardone, Antonio Carrillo-Vico
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease of unknown etiology characterized by infiltration of encephalitogenic cells in the central nervous system (CNS) resulting in the presence of multifocal areas of demyelination leading to neurodegeneration. The infiltrated immune cells population is composed mainly of effector CD4+ and CD8+ T lymphocytes, B cells, macrophages, and dendritic cells that secrete pro-inflammatory factors that eventually damage myelin leading to axonal damage. The most common clinical form of MS is relapsing-remitting (RR), characterized by neuroinflammatory episodes followed by partial or total recovery of neurological deficits...
July 26, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39067313/perivascular-b-cells-link-intestinal-angiogenesis-to-immunity-and-to-the-gut-brain-axis-during-neuroinflammation
#15
JOURNAL ARTICLE
Benjamin Peter, Jessica Rebeaud, Solenne Vigne, Valentine Bressoud, Nicholas Phillips, Florian Ruiz, Tatiana V Petrova, Jeremiah Bernier-Latmani, Caroline Pot
Disruption of gut barrier function and intestinal immune cell homeostasis are increasingly considered critical players in pathogenesis of extra-intestinal inflammatory diseases, including multiple sclerosis (MS) and its prototypical animal model, the experimental autoimmune encephalomyelitis (EAE). Breakdown of epithelial barriers increases intestinal permeability and systemic dissemination of microbiota-derived molecules. However, whether the gut-vascular barrier (GVB) is altered during EAE has not been reported...
July 26, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39059058/epidemiologic-and-genetic-associations-between-primary-biliary-cholangitis-and-extrahepatic-rheumatic-diseases
#16
JOURNAL ARTICLE
Qiwei Qian, Yi Wu, Nana Cui, Yikang Li, Yujie Zhou, You Li, Min Lian, Xiao Xiao, Qi Miao, Zhengrui You, Qixia Wang, Yongyong Shi, Heather J Cordell, Suraj Timilsina, M Eric Gershwin, Zhiqiang Li, Xiong Ma, Ruqi Tang
Patients with primary biliary cholangitis (PBC) commonly experience extrahepatic rheumatic diseases. However, the epidemiologic and genetic associations as well as causal relationship between PBC and these extrahepatic conditions remain undetermined. In this study, we first conducted systematic review and meta-analyses by analyzing 73 studies comprising 334,963 participants across 17 countries and found strong phenotypic associations between PBC and rheumatic diseases. Next, we utilized large-scale genome-wide association study summary data to define the shared genetic architecture between PBC and rheumatic diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and Sjögren's syndrome (SS)...
July 25, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39033688/functional-metagenomic-analysis-reveals-potential-inflammatory-triggers-associated-with-genetic-risk-for-autoimmune-disease
#17
JOURNAL ARTICLE
Meghan A Berryman, Jorma Ilonen, Eric W Triplett, Johnny Ludvigsson
To assess functional differences between the microbiomes of individuals with autoimmune risk-associated human leukocyte antigen (HLA) genetics and autoimmune protection-associated HLA, we performed a metagenomic analysis of stool samples from 72 infants in the All Babies in Southeast Sweden general-population cohort and assessed haplotype-peptide binding affinities. Infants with risk-associated HLA DR3-DQ2.5 and DR4-DQ8 had a higher abundance of known pathogen-associated molecular patterns and virulence related genes than infants with protection-associated HLA DR15-DQ6...
July 20, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39033687/high-fat-diet-modulates-bile-acid-composition-and-gut-microbiota-affecting-severe-cholangitis-and-cirrhotic-change-in-murine-primary-biliary-cholangitis
#18
JOURNAL ARTICLE
Masahiro Umemura, Akira Honda, Maho Yamashita, Takeshi Chida, Hidenao Noritake, Kenta Yamamoto, Takashi Honda, Mayuko Ichimura-Shimizu, Koichi Tsuneyama, Teruo Miyazaki, Nobuhito Kurono, Patrick S C Leung, M Eric Gershwin, Takafumi Suda, Kazuhito Kawata
Increasing evidence suggests that, in addition to a loss of tolerance, bile acid (BA) modulates the natural history of primary biliary cholangitis (PBC). We focused on the impacts of dietary changes on the immunopathology of PBC, along with alterations in BA composition and gut microbiota. In this study, we have taken advantage of our unique PBC model, a Cyp2c70/Cyp2a12 double knockout (DKO), which includes a human-like BA composition, and develops progressive cholangitis following immunization with the PDC-E2 mimic, 2-octynoic acid (2OA)...
July 20, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/39033686/immune-mediated-necrotizing-myopathy-a-comprehensive-review-of-the-pathogenesis-clinical-features-and-treatments
#19
REVIEW
Changpei Li, Hongjiang Liu, Leiyi Yang, Ruiting Liu, Geng Yin, Qibing Xie
Immune-mediated necrotizing myopathy (IMNM) is a rare and newly recognized autoimmune disease within the spectrum of idiopathic inflammatory myopathies. It is characterized by myositis-specific autoantibodies, elevated serum creatine kinase levels, inflammatory infiltrate, and weakness. IMNM can be classified into three subtypes based on the presence or absence of specific autoantibodies: anti-signal recognition particle myositis, anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myositis, and seronegative IMNM...
July 20, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38972102/impact-of-coding-risk-variant-ifngr2-on-the-b-cell-intrinsic-ifn-%C3%AE-signaling-pathway-in-multiple-sclerosis
#20
JOURNAL ARTICLE
Laurens Bogers, Jasper Rip, Liza Rijvers, Jamie van Langelaar, Steven C Koetzier, Kirsten L Kuiper, Veronique Meerdink, Annet F Wierenga-Wolf, Marie-José Melief, Ana M Marques, Joost Smolders, Marvin M van Luijn
B cells of people with multiple sclerosis (MS) are more responsive to IFN-γ, corresponding to their brain-homing potential. We studied how a coding single nucleotide polymorphism (SNP) in IFNGR2 (rs9808753) co-operates with Epstein-Barr virus (EBV) infection as MS risk factors to affect the IFN-γ signaling pathway in human B cells. In both cell lines and primary cells, EBV infection positively associated with IFN-γ receptor expression and STAT1 phosphorylation. The IFNGR2 risk SNP selectively promoted downstream signaling via STAT1, particularly in transitional B cells...
July 6, 2024: Journal of Autoimmunity
journal
journal
29968
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.